Cognitive-Behavioral and Pharmacologic (LDX) Treatment of Binge-Eating Disorder and Obesity: Medication Change for Non-Responders

Conditions:   Binge-Eating Disorder;   Obesity Interventions:   Drug: Naltrexone and Bupropion;   Other: Placebo Sponsor:   Yale University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials